Amcad Biomed Corp 4188
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 22.85
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, a software solution for thyroid nodules analysis; AmCAD-UV, a software device that is used for quantifying and classifying the ultrasonic color intensity data acquired from FDA-cleared ultrasound systems and displaying the noise-reduced color-coded pulsatile signals; AmCAD- U.S, a software device for viewing and quantifying ultrasound image data of backscattered signals; and AmCAD-UO offers detection for obstructive sleep apnea on awake patients to identify the root cause of sleep apnea. The company's geographical segments include Taiwan, China, and other countries, out of which the majority of the revenue is generated from China.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 34
- Website
- https://www.amcad.com.tw
Valuation
|
Metric
|
4188
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.89 |
Price/Sales | 22.85 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
4188
|
|---|---|
Quick Ratio | 12.23 |
Current Ratio | 13.35 |
Interest Coverage | −384.79 |
Quick Ratio
4188
Profitability
|
Metric
|
4188
|
|---|---|
Return on Assets (Normalized) | −7.98% |
Return on Equity (Normalized) | −10.49% |
Return on Invested Capital (Normalized) | −9.12% |
Return on Assets
4188
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Qfxkqlgcc | Drvtn | $185.5 Bil | |
SYK
| Stryker Corp | Cghtntfsrq | Sswvn | $128.2 Bil | |
MDT
| Medtronic PLC | Svztttwx | Njskdg | $106.7 Bil | |
BSX
| Boston Scientific Corp | Grnmgswm | Kdwvb | $99.0 Bil | |
DXCM
| DexCom Inc | Tjdhnysrk | Wqd | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Tlvlqvqwr | Zdvjz | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Jwkrxwkb | Gvjv | $24.9 Bil | |
ALGN
| Align Technology Inc | Vzlwpcn | Xvjxfbz | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Rslqryqv | Yybrs | $18.9 Bil | |
PODD
| Insulet Corp | Vczlnnpcp | Prxhpk | $11.7 Bil |